Side-by-side comparison of AI visibility scores, market position, and capabilities
Indianapolis agricultural seeds and crop protection (NYSE: CTVA) $17.2B FY2024 revenue; Pioneer Hi-Bred seeds, Enlist weed system, Qrome corn traits, competing with Bayer Crop Science and Syngenta.
Corteva, Inc. is an Indianapolis, Indiana-based agricultural science company — publicly traded on the New York Stock Exchange (NYSE: CTVA) as an S&P 500 Materials component — developing and selling seeds (Pioneer brand corn, soybean, sunflower, and vegetable seeds) and crop protection products (herbicides, insecticides, fungicides under Enlist, Instinct, Zorvec, and other brands) to farmers across 140 countries through approximately 22,000 employees. Corteva was spun off from DowDuPont in June 2019 as the agricultural science component of the DowDuPont three-way breakup (materials science → Dow Inc., specialty products → DuPont de Nemours, agriculture → Corteva), combining the Pioneer Hi-Bred seed genetics legacy (acquired by DuPont in 1999 for $9.4 billion) with the Dow AgroSciences crop protection portfolio. In fiscal year 2024, Corteva reported revenues of $17.2 billion, with the Seed segment (corn, soybean, and specialty crop seeds) generating $9.3 billion and the Crop Protection segment (pesticides, herbicides, fungicides) generating $7.9 billion — though crop protection faced market headwinds from generic agrochemical price competition and grower inventory destocking as global commodity crop prices fell from 2022-2023 peaks. CEO Chuck Magro's strategy focuses on driving pricing power through genetic trait performance (Corteva's Qrome corn trait technology delivering 5-10 bushel/acre yield advantage driving premium seed pricing) and the Enlist weed control system (herbicide-tolerant soybeans paired with Enlist Duo herbicide through a closed IP system that bundles herbicide and trait royalty revenue).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.